Dr. An Martens SRL
Dr. An Martens reported total assets of 219,416 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Apr 2026).
The score of Dr. An Martens shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -99 % Total assets -28 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. An Martens's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 211,806 € | ||||
| Equity | 2,500 € | ||||
| Cash | 119,930 € | ||||
| EBITDA | 279,257 € | ||||
| Total assets | 219,416 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Apr 2026
- Year ended 31 Dec 2024filed on 09 Jul 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
Dr. An Martens's financial analysis
- Solvency1.1%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. An Martens
Dr. An Martens's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0746.401.241
- VAT number
- BE0746401241
- Peppol
- Registered · 0208:0746401241 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Apr 2020
- Registered office
- 2800 Mechelen
- Latest accounts
- 2025 · filed on 14 Apr 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. An Martens (SRL) has been based in Mechelen since 2020, active in: medical specialists activities. For 2025, it reports a net profit of 211,806 € and equity of 2,500 €; its revenue is not published. Its solvency stands at 1.1%, below the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. An Martens
Companies in the same business, of comparable size and area, outside its group.
- Mind AF Medical specialists activities Duffel · balance sheet 19 €
- Coigne Etienne Dokter Medical specialists activities Ypres · balance sheet 220,117 €
- Dokter Michiel Boon Medical specialists activities Tielt-Winge · balance sheet 223,705 €
- Dr. Aurelie Minne Medical specialists activities Izegem · balance sheet 212,079 €
- Dr. Ghislaine Peene Medical specialists activities Kortrijk · balance sheet 232,976 €
- Cardiorhythmics Medical specialists activities Antwerp · balance sheet 233,563 €
- Dr. Kris Gillis Medical specialists activities Roeselare · balance sheet 238,082 €
- Dr. Louise van Steen - Psychiater Medical specialists activities Izegem · balance sheet 260,553 €
Frequently asked questions about Dr. An Martens
What is the revenue of Dr. An Martens?
Dr. An Martens files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. An Martens?
In Belgium, the VAT number is the company number prefixed with BE: BE0746401241 for Dr. An Martens, if the company is VAT-registered. Its company number (CBE) is 0746.401.241.
Where is the registered office of Dr. An Martens?
According to the CBE register, the registered office of Dr. An Martens is in 2800 Mechelen.
What is the equity of Dr. An Martens?
At the close of the 2025 financial year, the equity of Dr. An Martens amounts to 2,500 €, a solvency of 1.1% of total assets.
Who manages Dr. An Martens?
The register lists 1 active mandates at Dr. An Martens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. An Martens
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →